Podcast: Play in new window | Download (Duration: 37:51 — 34.7MB) | Embed

Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | iHeartRadio | Blubrry | Podcast Index | TuneIn | Deezer | RSS | More

Voicing New Reasons for Optimism

HOST: Hildy Grossman, CO-HOST: Jordan Rich
GUEST: Maida Mangiameli, Dusty Donaldson, Misty Shields, MD, Ph.D., and Ann Steagall

Small cell lung cancer (SCLC) is a highly aggressive form of lung cancer with a 5-year survival rate of just 7%, a disheartening statistic. Despite this, survivors, researchers, and the medical community are actively working to create a more hopeful future. In this powerful podcast episode, we bring together a diverse team of guests to discuss stories of survival, groundbreaking treatments, and renewed reasons for hope. You’ll hear from:
• Maida Mangiameli, an inspiring SCLC survivor who’s been in remission for 8 years, so far.
• Dr. Misty Shields, a physician-scientist specializing in SCLC within her oncology practice who also shares a personal story.
• Dusty Donaldson, a lung cancer survivor and patient-advocate whose organization provides crucial support groups for SCLC patients.
• Ann Steagall, a dedicated nurse navigator who guides patients through their diagnosis and treatment journey.
Join us for a lively discussion that sheds light on the progress being made and the hope that exists for those facing small cell lung cancer.

Podcast: Play in new window | Download (Duration: 42:31 — 38.9MB) | Embed

Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | iHeartRadio | Blubrry | Podcast Index | TuneIn | Deezer | RSS | More

HOST: Hildy Grossman, CO-HOST: Jordan Rich
GUESTS: Carl Gay, MD, MD Anderson, Misty Shields, MD, Ph.D., Indiana University Simon Comprehensive Cancer Center.

Hildy shares her experience of losing a friend who was diagnosed with neuroendocrine tumors of the gastrointestinal system. Knowing that neuroendocrine cells are present in the lungs prompted Hildy to wonder if lung cancer drugs would possibly be viable in treating her friend’s condition. This podcast looks at small cell lung cancer which is a kind of aggressive neuroendocrine tumor and less aggressive, carcinoid neuroendocrine tumors. Experts Dr. Carl Gay and Dr. Misty Shields discuss how little is known about the neuroendocrine system, even among oncologists. Neuroendocrine small cell tumors in the lungs and other areas of the body are associated with tobacco use and vaping. The less aggressive, low grade, carcinoid tumors have unclear causes. The discussion includes how these tumors are diagnosed, challenges for treatment, drug resistance and recurrence. Our guests also highlight the importance of research, and new therapies that give hope to these patients.